Eag1 channels as potential early-stage biomarkers of hepatocellular carcinoma

Código QR

Eag1 channels as potential early-stage biomarkers of hepatocellular carcinoma

María de Guadalupe Chávez-López,1 Violeta Zúñiga-García,1 Julio Isael Pérez-Carreón,2 Arturo Avalos-Fuentes,3 Yesenia Escobar,4 Javier Camacho1 1Department of Pharmacology, Centro de Investigación y de...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Chávez-López MG, Zúñiga-García V, Pérez-Carreón JI, Avalos-Fuentes A, Escobar Y, Camacho J
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2016
Materias:	Ion channels Eag1 Hepatocellular carcinoma Astemizole Diethylnitrosamine Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/79814a29c0b94e63834918170d2e7785
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Protective effect of Cassia fistula Linn. on diethylnitrosamine induced hepatocellular damage and oxidative stress in ethanol pretreated rats
por: PRADEEP,KANNAMPALLI, et al.
Publicado: (2010)

Detección serológica de Bartonella henselae en gatos en la ciudad de Valdivia, Chile
por: ZAROR,L., et al.
Publicado: (2002)

Photopharmacology of Ion Channels through the Light of the Computational Microscope
por: Alba Nin-Hill, et al.
Publicado: (2021)

Bartonelosis ocular: Report of three clinical cases
por: Täger F,Marlis, et al.
Publicado: (2008)

Electrophysiological and behavioral responses of pea weevil Bruchus pisorum L. (Coleóptera: Bruchidae) to volatiles collected from its host Pisum sativum L
por: Ceballos,Ricardo, et al.
Publicado: (2015)

Transthyretin as a Novel Biomarker for Diagnosis of Hepatocellular Carcinoma in Cirrhotic Patients
por: Magda Ibrahim, et al.
Publicado: (2020)

Behavioral and antennal responses of Lobesia botrana (Lepidoptera: Tortricidae) to volatiles from the non-host plant Schinus molle L. (Anacardiaceae)
por: Silva,Diego, et al.
Publicado: (2019)

Amphiregulin as a novel diagnostic and prognostic biomarker of hepatocellular carcinoma before and after locoregional treatment
por: Amira Isaac, et al.
Publicado: (2021)

Novel model of calcium and inositol 1,4,5-trisphosphate regulation of InsP3 receptor channel gating in native endoplasmic reticulum
por: Foskett,J. Kevin, et al.
Publicado: (2004)

The Efficacy and Prognostic Factors of the Combination of TACE and Apatinib for the Treatment of BCLC Stage C Hepatocellular Carcinoma
por: Shun Liu, et al.
Publicado: (2021)

NDRG2 inhibition facilitates angiogenesis of hepatocellular carcinoma
por: Wang Jianlong, et al.
Publicado: (2021)

Involvement of K+ATP and Ca2+ channels in hydrogen sulfide-suppressed ageing of porcine oocytes
por: Nevoral,Jan, et al.
Publicado: (2018)

On Efficacy of Microwave Ablation in the Thermal Treatment of an Early-Stage Hepatocellular Carcinoma
por: Branislav Radjenović, et al.
Publicado: (2021)

Lenvatinib as the key component of first-line therapy for patients with unresectable hepatocellular carcinoma
por: L. V. Bolotina
Publicado: (2020)

Prediction of early recurrence and response to adjuvant Sorafenib for hepatocellular carcinoma after resection
por: Liming Zheng, et al.
Publicado: (2021)

Diabetes mellitus does not influence results of hepatectomy in hepatocellular carcinoma: case control study
por: Yoshihiro Inoue, et al.
Publicado: (2021)

Calcium-Dependent Ion Channels and the Regulation of Arteriolar Myogenic Tone
por: William F. Jackson
Publicado: (2021)

Overexpression of PIK3R1 promotes hepatocellular carcinoma progression
por: Ai,Xuejun, et al.
Publicado: (2018)

Identification and Validation of TYMS as a Potential Biomarker for Risk of Metastasis Development in Hepatocellular Carcinoma
por: Shuai Li, et al.
Publicado: (2021)

Integrated Bioinformatics Analysis Identifies Heat Shock Factor 2 as a Prognostic Biomarker Associated With Immune Cell Infiltration in Hepatocellular Carcinoma
por: Yumei Fan, et al.
Publicado: (2021)

IMMUNOHISTOCHEMICAL EXPRESSION OF GLYPICAN-3 IN HEPATOCELLULAR CARCINOMA
por: Dr Syed Salman Ali, et al.
Publicado: (2018)

Viral Hepatitis and Hepatocellular Carcinoma: State of the Art
por: Toofan Datfar, et al.
Publicado: (2021)

Development of a Model to Predict Liver Decompensation prior to Transarterial Chemoembolization Refractoriness in Patients with Intermediate-Stage Hepatocellular Carcinoma
por: Joel Ferreira-Silva, et al.
Publicado: (2021)

Role of CD5L and SRD5A2 as Prognostic Biomarkers for Hepatocellular Carcinoma
por: Luo Y, et al.
Publicado: (2021)

Manuka honey enhanced sensitivity of HepG2, hepatocellular carcinoma cells, for Doxorubicin and induced apoptosis through inhibition of Wnt/β-catenin and ERK1/2
por: Al Refaey,Heba R., et al.
Publicado: (2021)

Hepatocarcinoma con invasión cardiovascular: comunicación de 5 casos y revisión de la literatura
por: Valera M,José M, et al.
Publicado: (2004)

Bioinformatics Analysis Identifies Precision Treatment with Paclitaxel for Hepatocellular Carcinoma Patients Harboring Mutant <i>TP53</i> or Wild-Type <i>CTNNB1</i> Gene
por: Jiunn-Chang Lin, et al.
Publicado: (2021)

A Novel Treatment Strategy for Patients with Intermediate-Stage HCC Who Are Not Suitable for TACE: Upfront Systemic Therapy Followed by Curative Conversion
por: Masatoshi Kudo
Publicado: (2021)

miR-221 Suppression Through Nanoparticle-Based miRNA Delivery System for Hepatocellular Carcinoma Therapy and Its Diagnosis as a Potential Biomarker [Corrigendum]
por: Li F, et al.
Publicado: (2020)

Histidines 13 and 14 in the Aβ sequence are targets for inhibition of Alzheimer's disease Aβ ion channel and cytotoxicity
por: DÍAZ,JUAN CARLOS, et al.
Publicado: (2006)

Hospital Frailty Risk Score Is Independently Associated with Mortality and Encephalopathy in Hospitalized Patients with Hepatocellular Carcinoma
por: Daryl Ramai, et al.
Publicado: (2021)

CDT1 Is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma
por: Chenhui Cai, et al.
Publicado: (2021)

miR-221 suppression through nanoparticle-based miRNA delivery system for hepatocellular carcinoma therapy and its diagnosis as a potential biomarker
por: Li F, et al.
Publicado: (2018)

An update on subtypes of hepatocellular carcinoma: From morphology to molecular
por: Monika Vyas, et al.
Publicado: (2021)

Treatment for Viral Hepatitis as Secondary Prevention for Hepatocellular Carcinoma
por: Saleh A. Alqahtani, et al.
Publicado: (2021)

Corrigendum: CDT1 is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma
por: Chenhui Cai, et al.
Publicado: (2021)

Expression Profile and Ligand Screening of a Putative Odorant-Binding Protein, AcerOBP6, from the Asian Honeybee
por: Huiting Zhao, et al.
Publicado: (2021)

Alterations in the Gut Microbiome in the Progression of Cirrhosis to Hepatocellular Carcinoma
por: Yelena Lapidot, et al.
Publicado: (2020)

Expression and Clinical Significance of MPS-1 in Hepatocellular Carcinoma
por: Jiang H, et al.
Publicado: (2021)

Hepatocarcinoma, porfiria y hemosiderosis. Una asociación no reportada en nuestro país: Caso clínico
por: WHITTLE,CAROLINA, et al.
Publicado: (2010)